dexamethasone 21-phosphate has been researched along with Ocular Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bunya, VY; Dunn, JP; Gritz, DC; Huang, J; Kempen, JH; Maguire, MG; McWilliams, K; O'Neil, EC; Perez, VL; Peskin, E; Suhler, EB; Ying, GS | 1 |
| Baldaniya, L; Gandhi, T; Gohel, M; Metalia, V; Patel, N; Thakkar, V | 1 |
2 other study(ies) available for dexamethasone 21-phosphate and Ocular Infections
| Article | Year |
|---|---|
Iontophoretic delivery of dexamethasone phosphate for non-infectious, non-necrotising anterior scleritis, dose-finding clinical trial.
Topics: Anterior Eye Segment; Dexamethasone; Dose-Response Relationship, Drug; Double-Blind Method; Drug Delivery Systems; Eye Infections; Female; Glucocorticoids; Humans; Iontophoresis; Male; Middle Aged; Necrosis; Randomized Controlled Trials as Topic; Scleritis; Treatment Outcome | 2018 |
Formulation and development of ophthalmic in situ gel for the treatment ocular inflammation and infection using application of quality by design concept.
Topics: Administration, Ophthalmic; Animals; Biological Availability; Chemistry, Pharmaceutical; Delayed-Action Preparations; Dexamethasone; Drug Delivery Systems; Excipients; Eye Infections; Female; Gels; Hypromellose Derivatives; Inflammation; Male; Ophthalmic Solutions; Poloxamer; Rabbits; Temperature; Tobramycin | 2016 |